Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure
Hypertension and heart failure are important contributors to global morbidity and mortality. Despite therapeutic lifestyle and pharmacological measures, a significant proportion of people with hypertension do not reach treatment targets. Patients with resistant or poorly controlled hypertension are...
Main Authors: | Anna Meta Dyrvig Kristensen, Manan Pareek, Michael Hecht Olsen, Deepak L Bhatt |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-02-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2019.13.2 |
Similar Items
-
Baroreflex Activation Therapy for the Treatment of Drug-Resistant Hypertension: New Developments
by: Teba Alnima, et al.
Published: (2012-01-01) -
Myocardial infarction with simultaneous anterior and inferior ST‐segment elevation
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2019-03-01) -
Conservatively managed saddle pulmonary embolism
by: Anna Meta Dyrvig Kristensen, et al.
Published: (2019-06-01) -
Comment on “Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction”
by: Mário Oliveira
Published: (2015-12-01) -
Baroreflex sensitivity in patients with chronic heart failure: the clinical significance and impact of therapy
by: Mikhail Viktorovich Nepoklonov, et al.
Published: (2010-12-01)